The invention relates to octapeptides being octreotide derivatives and also to imaging agents based on it used to diagnose tumours i.e. in chemistry and medicine. Octapeptide being an octreotide derivative has common formula (1):where X and Y are H or chelating group namely OTA covalently bound to �� - or ��-amino groups of N end lysine. Octapeptide with formula (1) forms a chelating complex with radionuclides e.g. in the form of gallium isotopes 68Ga 66Ga 67Ga to obtain the imaging agent.The im...

The present invention relates to sustained release formulations comprising as active ingredient octreotide or a pharmaceutically-acceptable salt thereof and two different linear polylactide-co-glycolide polymers (PLGAs).

A pharmaceutical composition comprises octreotide acetate microparticles of linear poly(lactide-co-glycolide) polymer wherein the polymer contains less than 1% silicone oil or heptane.

The present invention provides a sterile solution comprising octreotide acetate in a pharmaceutically acceptable vehicle wherein solution is present as a reservoir in a multiple dose pen injection device the device being adapted to subcutaneously inject a portion of the said reservoir in multiple daily doses and further being adapted to provide multiple portions of the said solution while the reservoir remains sterile.

The present invention provides a sterile solution comprising octreotide acetate in a pharmaceutically acceptable vehicle wherein solution is present as a reservoir in a multiple dose pen injection device the device being adapted to subcutaneously inject a portion of the said reservoir in multiple daily doses and further being adapted to provide multiple portions of the said solution while the reservoir remains sterile.

The present invention provides a sterile solution comprising octreotide acetate in a pharmaceutically acceptable vehicle, wherein solution is present as a reservoir in a multiple dose pen injection device, the device being adapted to subcutaneously inject a portion of the said reservoir in multiple daily doses and further being adapted to provide multiple portions of the said solution, while the reservoir remains sterile.

The present invention provides a sterile solution comprising octreotide acetate in a pharmaceutically acceptable vehicle wherein solution is present as a reservoir in a multiple dose pen injection device the device being adapted to subcutaneously inject a portion of the said reservoir in multiple daily doses and further being adapted to provide multiple portions of the said solution while the reservoir remains sterile.

The present invention relates to a method of stimulating the motility of the gastrointestinal system in a subject in need thereof wherein the subject suffers from maladies (i.e. disorders or diseases) of the gastrointestinal system. The method comprises administering to a subject in need thereof a therapeutically effective amount of a growth hormone secretagogue compound or a pharmaceutically acceptable salt hydrate or solvate thereof. The growth hormone secretagogue can be co-administered with ...